Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study

What is it about?

Synthetic cannabinoids are a popular alternative for cannabis. We tested for the first time the effects of 2 doses of a synthetic cannabinoid in 6 healthy volunteers. We did demonstrate some cognitive impairments, even though drug concentrations were relatively low.

Featured Image